1,672
Views
2
CrossRef citations to date
0
Altmetric
Clinical Research

Effect of Agkistrodon halys antivenom in patients bit by green pit viper and the prognostic role of the disease – a retrospective cohort study

ORCID Icon, ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 808-817 | Received 24 Sep 2021, Accepted 07 Feb 2022, Published online: 28 Feb 2022

References

  • Lancet T. Snake-bite envenoming: a priority neglected tropical disease. Lancet. 2017;390:2.
  • Albulescu LO, Hale MS, Ainsworth S, et al. Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite. Sci Transl Med. 2020;12(542):eaay8314.
  • Gutiérrez JM, Calvete JJ, Habib AG, et al. Snakebite envenoming. Nat Rev Dis Primers. 2017;3(1):1–21.
  • WHO. Guidelines for the production control and regulation of snake antivenom immunoglobulins. Geneva, Switzerland: World Health Organization; 2010.
  • WHO. Guidelines for the prevention and clinical management of snakebite in Africa, in, world health organization. Congo, Central Africa: WHO Regional Office for Africa; 2010.
  • Consensus Expert Group of Chinese Snake Wound Treatment Experts. Expert consensus on treatment of snake wounds in China in 2018. Chin J Emerg Med. 2018;27:1315–1322.
  • Minghui R, Malecela MN, Cooke E, et al. WHO's Snakebite Envenoming Strategy for prevention and control. The Lancet Global Health. 2019;7(7):e837–e838.
  • Habib AG, Brown NI. The snakebite problem and antivenom crisis from a health-economic perspective. Toxicon. 2018;150:115–123.
  • Brown N, Landon J. Antivenom: the most cost-effective treatment in the world? Toxicon. 2010;55(7):1405–1407.
  • Jayawardana S, Arambepola C, Chang T, et al. Prevalence, vulnerability and epidemiological characteristics of snakebite in agricultural settings in rural Sri Lanka: a population-based study from South Asia. PLoS One. 2020;15(12):e0243991.
  • Knudsen C, Jürgensen JA, Føns S, et al. Snakebite envenoming diagnosis and diagnostics. Front Immunol. 2021;12:661457.
  • Hung DZ. Taiwan’s venomous snakebite: epidemiological, evolution and geographic differences. Trans R Soc Trop Med Hyg. 2004;98(2):96–101.
  • Alirol E, Sharma SK, Bawaskar HS, et al. Snake bite in South asia: a review. PLoS Negl Trop Dis. 2010;4(1):e603.
  • Liu Q, Zeng ZY, Zhang CC. Epidemiological characteristics of poisonous snakebites in Shenzhen city. Guangxi Med J. 2018;40:54–56.
  • Peng G. Taxonomic and phylogenetic studies on Trimeresurus (S.L.) (Serpentes: Crotalinae). ChengDu, China: Sichuan University; 2005.
  • Rathnayaka RN, Kularatne SAM, Ranathunga P. Coagulopathy and extensive local swelling following green pit viper (trimeresurus trigonocephalus) envenoming in Sri Lanka. Toxicon. 2017;129:95–99.
  • Rojnuckarin P, Intragumtornchai T, Sattapiboon R, et al. The effects of green pit viper (trimeresurus albolabris and trimeresurus macrops) venom on the fibrinolytic system in human. Toxicon. 1999;37(5):743–755.
  • Rathnayaka RN, Ranathunga P, Kularatne SAM. Epidemiology and clinical features of green pit viper (Trimeresurus trigonocephalus) envenoming in Sri Lanka. Toxicon. 2017;137:99–105.
  • David P. Les serpents venimeux du monde: systématique et répartition. Dumerilia. 1999;3:3–499.
  • McDiarmid RW, Campbell JA, Touré T. Snake species of the world: a taxonomic and geographic reference. Washington (DC): Herpetologists‘ League; 1999.
  • Ermi Z. Chinese zoology reptiles volume three scaly snakes. Beijing: Science Press; 1998.
  • Huang PY, Zeng ZY, Liu Q, et al. Epidemiological investigation and analysis of influencing factors before hospital on the bite of Trimeresurus stejnegeri. J Clin Emerg. 2020;21(05):393–396 + 401.
  • Chiang LC, Tsai WJ, Liu PY, et al. Envenomation by Trimeresurus stejnegeri stejnegeri: clinical manifestations, treatment and associated factors for wound necrosis. J Venom Anim Toxins Incl Trop Dis. 2020;26:e20200043.
  • Yee KT, Maw LZ, Kyaw AM, et al. Evaluation of the cross-neutralization capacity of Thai green pit viper antivenom against venom of Myanmar green pit viper. Toxicon. 2020;177:41–45.
  • Fung HT, Yung WH, Crow P, et al. Green pit viper antivenom from Thailand and agkistrodon halys antivenom from China compared in treating cryptelytrops albolabris envenomation of mice. Hong Kong Med J. 2012;18(1):40–45.
  • Yang JYK, Hui H, Lee ACW. Severe coagulopathy associated with white-lipped green pit viper bite. Hong Kong Med J. 2007;13(5):392–395.
  • Lavonas EJ, Kokko J, Schaeffer TH, et al. Short-term outcomes after fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011;57(2):128–137.e3.
  • Rha JH, Kwon SM, Oh JR, et al. Snakebite in Korea: a guideline to primary surgical management. Yonsei Med J. 2015;56(5):1443–1448.
  • Mong R, Ng VCH, Tse ML. Safety profile of snake antivenom (use) in Hong Kong - a review of 191 cases from 2008 to 2015. Clin Toxicol (Phila). 2017;55(10):1066–1071.
  • Lam SK, Yip SF, Crow P, et al. Comparison of green pit viper and Agkistrodon halys antivenom in inhibition of coagulopathy due to Trimeresurus albolabris venom: an in-vitro study using human plasma. Hong Kong Med J. 2017;23(1):13–18.
  • Management of Snakebite. Accident and emergency clinical guidelines number 9. Hong Kong: Central Coordinating Committee of Accident and Emergency Services, Hospital Authority; 2008.
  • Oh H, Shin J, Ato M, et al. The first meeting of the national control laboratories for vaccines and biologicals in the Western Pacific in 2016. Osong Public Health Res Perspect. 2017;8(1):91–103.
  • Yong MY, Tan KY, Tan CH. Potential Para-specific and geographical utility of thai green pit viper (Trimeresurus albolabris) monovalent antivenom: neutralization of procoagulant and hemorrhagic activities of diverse trimeresurus pit viper venoms. Toxicon. 2021;203:85–92.
  • Ownby CL, Colberg TR. Comparison of the immunogenicity and antigenic composition of several venoms of snakes in the family crotalidae. Toxicon. 1990;28(2):189–199.
  • Gao JF, Wang J, Qu YF, et al. Immunoreactivity between venoms and commercial antiserums in four Chinese snakes and venom identification by species-specific antibody. J Immunol Methods. 2013;387(1–2):211–218.
  • Van Dong L, Quyen LK, Eng KH, et al. Immunogenicity of venoms from four common snakes in the South of Vietnam and development of ELISA kit for venom detection. J Immunol Methods. 2003;282(1–2):13–31.
  • Gutiérrez JM, Lomonte B, León G, et al. Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. J Proteomics. 2009;72(2):165–182.
  • Tan NH, Tan KY, Tan CH. Snakebite in Southeast Asia: envenomation and clinical management. Handbook of venoms and toxins of reptiles. Boca Raton (FL): CRC Press; 2021.
  • Isbister GK, Brown SGA, Page CB, et al. Snakebite in Australia: a practical approach to diagnosis and treatment. Med J Aust. 2013;199(11):763–768.
  • Vaiyapuri S, Vaiyapuri R, Ashokan R, et al. Snakebite and its socio-economic impact on the rural population of Tamil Nadu, India. PLoS One. 2013;8(11):e80090.
  • Habib AG, Warrell DA. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in west Africa. Toxicon. 2013;69:82–89.
  • Visser LE, Kyei-Faried S, Belcher DW, et al. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans R Soc Trop Med Hyg. 2008;102(5):445–450.
  • Wei WL. Application of anti-Agkistrodon halys venom serum and anti-Agkistrodon acutus venom serum in the treatment of bite of Trimeresurus stejnegeri snake. J Snake. 2021;33(3):3.
  • Cai TT, Li TX, Ye YQ, et al. Selection and optimization of antivenom serum in treatment of Trimeresurus stej-negeri snakebite poisoning. J Snake. 2021;33(02):121–124.
  • Zhang YA. Comparative study of Chinese medicine combined with two antivenom in the treatment of green pit viper bites. Guangdong, China: Guangzhou University of Chinese Medicine; 2020.
  • Kalantri S, Singh A, Joshi R, et al. Clinical predictors of in‐hospital mortality in patients with snake bite: a retrospective study from a rural hospital in Central India. Trop Med Int Health. 2006;11(1):22–30.